The economic case for investing in tobacco cessation
Despite decades of progress in reducing the prevalence of cigarette smoking, tobacco use remains a leading cause of preventable death and disease, and a significant driver of health care costs in the United States. Smoking cessation therapy is consistently ranked among the most cost-effective clinical preventive services and is considered to be “the gold standard of health care cost-effectiveness.” Yet, delivery of evidence-based treatment …
The economic case for investing in tobacco cessation

















